Douglas Hurd

Title: Douglas Hurd - Innovator in Assay Systems

Introduction

Douglas Hurd is a distinguished inventor based in Oxford, GB. With a remarkable portfolio that includes three patents, Hurd has made significant contributions to the field of assay systems, particularly in the realm of drug screening.

Latest Patents

His latest innovation involves a reverse two-hybrid system that utilizes post-translation signal modulation. This invention centers around modified two-hybrid systems, specifically a reverse two-hybrid system that employs a reporter gene encoding a modifying agent, such as an enzyme. The signal agent is typically modified by the enzyme, often leading to its breakdown. This innovative system produces a detectable signal when there is an inhibition of binding between the two hybrid proteins. The implications of this invention are profound, as it holds considerable promise for enhancing drug screening processes.

Career Highlights

Douglas Hurd is currently associated with Amersham International Plc, where he continues to develop his groundbreaking work on assay systems. His expertise has positioned him as a leading figure in this specialized area, advancing both scientific knowledge and practical applications.

Collaborations

Throughout his career, Hurd has had the opportunity to collaborate with notable coworkers, including Rachel Alison Fallon and Michael White. These collaborations have further enriched his work, contributing to the innovative solutions generated within their field.

Conclusion

Douglas Hurd’s inventive spirit and dedication to research have established him as a key player in the development of advanced assay systems. His latest patents not only showcase his innovative capabilities but also underline the essential role of engineering novel technologies in improving drug discovery and medical research.